Legfrissebb próbák


EudraCT Number: 2022-001063-27 Sponsor Protocol Number: JZP385-202-01 Start Date: 2023-07-19
Sponsor Name: Cavion, Inc., a subsidiary of Jazz Pharmaceuticals, Inc.
Full Title: A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Seve...
Medical condition: Parkinson’s Disease
Disease: Version SOC Term Classification Code Term Level
20.0 10029205 - Nervous system disorders 10061536 Parkinson's disease PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) ES (Ongoing) PL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-002788-30 Sponsor Protocol Number: IMVT-1401-3202 Start Date: 2023-07-13
Sponsor Name: Immunovant Sciences, GmbH
Full Title: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
Medical condition: Thyroid Eye Disease (TED)
Disease: Version SOC Term Classification Code Term Level
23.1 100000004853 10084358 Thyroid eye disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) BE (Ongoing) LV (Ongoing) HU (Ongoing) SK (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-001396-16 Sponsor Protocol Number: OP0595-6 Start Date: 2023-07-07
Sponsor Name: Meiji Seika Pharma Co., Ltd.
Full Title: A Phase 3, Multi-Center, Randomized, Single-Blind Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complicated Ur...
Medical condition: Complicated urinary tract infection (cUTI), acute uncomplicated pyelonephritis (AP), hospital acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), and complicated ...
Disease: Version SOC Term Classification Code Term Level
21.0 10021881 - Infections and infestations 10080628 Complicated urinary tract infection LLT
20.1 10021881 - Infections and infestations 10079985 Uncomplicated pyelonephritis LLT
21.1 10021881 - Infections and infestations 10081414 Ventilator associated bacterial pneumonia LLT
20.1 10021881 - Infections and infestations 10079983 Complicated intra-abdominal infection LLT
21.1 10021881 - Infections and infestations 10081416 Hospital acquired bacterial pneumonia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SK (Ongoing) GR (Ongoing) ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-002877-27 Sponsor Protocol Number: CTRIAL-IE-21-29/NRG-GY019 Start Date: 2023-07-06
Sponsor Name: Cancer Trials Ireland
Full Title: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or P...
Medical condition: Primary low-grade serous carcinoma of the ovary or peritoneum.
Disease: Version SOC Term Classification Code Term Level
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10007107 Cancer of ovary LLT
21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10026340 Malignant neoplasm of peritoneum, unspecified LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2020-004917-10 Sponsor Protocol Number: TIGER Start Date: 2023-06-29
Sponsor Name: King's College London [...] 1. King's College London 2. King's College Hospital NHS Foundation Trust
Full Title: Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a phase 3, pan-European, two-gro...
Medical condition: Submacular haemorrhage secondary to exudative age-related macular degeneration
Disease: Version SOC Term Classification Code Term Level
20.0 100000004853 10075718 Exudative age-related macular degeneration LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2022-003005-30 Sponsor Protocol Number: AR-DEX-22-03 Start Date: 2023-06-28
Sponsor Name: Areteia Therapeutics, Inc.
Full Title: A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 24 weeks in participants with eosinop...
Medical condition: Eosinophilic Asthma
Disease: Version SOC Term Classification Code Term Level
21.1 10038738 - Respiratory, thoracic and mediastinal disorders 10068462 Eosinophilic asthma LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-003584-18 Sponsor Protocol Number: KKS-307 Start Date: 2023-06-26
Sponsor Name: Philipps University Marburg
Full Title: Tezepelumab (Anti-TSLP-mab) in progressive pulmonary fibrosis interstitial lung disease with evidence of eosinophilia
Medical condition: Progressive pulmonary fibrosis interstitial lung disease with evidence of eosinophilia
Disease: Version SOC Term Classification Code Term Level
21.1 10038738 - Respiratory, thoracic and mediastinal disorders 10021240 Idiopathic pulmonary fibrosis PT
21.1 10038738 - Respiratory, thoracic and mediastinal disorders 10022619 Interstitial pulmonary fibrosis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-003743-10 Sponsor Protocol Number: BPL-003-201 Start Date: 2023-06-22
Sponsor Name: Beckley Psytech Ltd.
Full Title: A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression
Medical condition: Treatment-Resistant Depression (TRD)
Disease: Version SOC Term Classification Code Term Level
21.1 10037175 - Psychiatric disorders 10057840 Major depression PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) PL (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-000430-42 Sponsor Protocol Number: 67953964MDD3003_VENTURA-LT Start Date: 2023-06-22
Sponsor Name: Janssen-Cilag International NV
Full Title: An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)
Medical condition: Major Depressive Disorder (MDD)
Disease: Version SOC Term Classification Code Term Level
21.1 100000004873 10025453 Major depressive disorder NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Ongoing) HU (Ongoing) CZ (Ongoing) PL (Ongoing) BG (Ongoing) ES (Ongoing) PT (Ongoing) SK (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-000692-39 Sponsor Protocol Number: IVY Start Date: 2023-06-19
Sponsor Name: Amsterdam University Medical Center
Full Title: Safety, tolerability and immunogenicity of intradermal mRNA SARS-CoV2 vaccination in patients with Fibrodysplasia Ossificans Progressiva
Medical condition: Fibrodyplasia Ossificans Progressiva (FOP)
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10068715 Fibrodysplasia ossificans progressiva PT
Population Age: Adults Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
3